6505--New - NTX Blood Bank Reagents (Identification/ Antibodies) | SAM.gov Opportunity | G2X

6505--New - NTX Blood Bank Reagents (Identification/ Antibodies)

Solicitation36C25722Q0845Notice typeCombined Synopsis/SolicitationDallas, TX

Attachments

2 files

Name	Type	Posted	Actions
36C25722Q0845_1.docx	DOCX	Jul 8, 2022	Download
RFQ 36C25722Q0845.pdf	PDF	Jul 8, 2022	Download

Version History

6505--New - NTX Blood Bank Reagents (Identification/ Antibodies)

Combined Synopsis36C25722Q0845Jul 8, 2022 · v2

LatestViewing

Opportunity Summary

The Department of Veterans Affairs has issued request for quotation (RFQ) 36C25722Q0845 for the procurement of blood bank reagents and reference laboratory testing services for patient specimens. The required supplies include 0.8% Resolve Panel C red cell reagents, ID-Micro Typing System Anti IGG gel cards, and MTS Diluent 2 buffers. Performance will take place at the VA North Texas Healthcare System laboratory in Dallas, Texas. The acquisition covers five ordering periods beginning November 1, 2022, and concluding October 31, 2027.

This solicitation is classified under NAICS 325413 for In-Vitro Diagnostic Substance Manufacturing and PSC 6505 for Drugs and Biologicals. No set-aside is used for this solicitation. Evaluation for award will be based on technical acceptability and price. Technical factors include a vendor's ability to provide all items in accordance with the statement of work, the provision of a letter of authorization if the offeror is not the manufacturer, and a minimum of a satisfactory past performance rating.

Submissions are due to the point of contact, Delphia Schoenfeld, by July 29, 2022, at 3:00 p.m. ET. The notice includes two attachments: a Word document and the official RFQ PDF. Questions regarding the requirements were due by July 20, 2022. Vendors are permitted to submit brand name or equal items for consideration, and the government may accept late quotes if they are determined to be advantageous.

Generated by Lumen AI

Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.

Opportunity Summary

Opportunity Details

Response deadline: Jul 29, 2022Expired 1416 days ago
NAICS: 325413 (opens in new tab)
PSC: 6505 (opens in new tab)
Set aside: —
Published: Jul 8, 2022
Updated: Jul 8, 2022
Agency: VETERANS AFFAIRS, DEPARTMENT OF
Office: VETERANS AFFAIRS, DEPARTMENT OF
Department: —
Source: View on SAM.gov (opens in new tab)

Contact and place of performance

Point of contact: Delphia Schoenfeld

Place of performance

Dallas, TX 75216

USA

Original Description

This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued. The solicitation number 36C25722Q0845 is issued as a request for quotation (RFQ). The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2022-06. The NAICS Code for this request for quotes is 325413 (1,250 Employees). No set-aside is used for this solicitation. The items being requested are as follows: ITEM NUMBER DESCRIPTION OF SUPPLIES/SERVICES QUANTITY UNIT 0001 13.00 PG Reagent: Red Cells, 0.8% Resolve Panel C Ordering Period 1 POP Begin: 11-01-2022 POP End: 10-31-2023 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals Blood Bank Reagents (Identification and Antibodies) 0002 50.00 PG ID-Micro Typing System, Anti IGG Gel Card Ordering Period 1 POP Begin: 11-01-2022 POP End: 10-31-2023 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals Blood Bank Reagents (Identification and Antibodies) 0003 12.00 BX ID- Micro Typing System Buffers, MTS Diluent 2, 100mL Ordering Period 1 POP Begin: 11-01-2022 POP End: 10-31-2023 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals Blood Bank Reagents (Identification and Antibodies) 1001 13.00 PG Reagent: Red Cells, 0.8% Resolve Panel C Ordering Period 2 POP Begin: 11-01-2023 POP End: 10-31-2024 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals Blood Bank Reagents (Identification and Antibodies) 1002 50.00 PG ID-Micro Typing System, Anti IGG Gel Card Ordering Period 2 POP Begin: 11-01-2023 POP End: 10-31-2024 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals Blood Bank Reagents (Identification and Antibodies) 1003 12.00 BX ID- Micro Typing System Buffers, MTS Diluent 2, 100mL Ordering Period 2 POP Begin: 11-01-2023 POP End: 10-31-2024 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals Blood Bank Reagents (Identification and Antibodies) 2001 13.00 PG Reagent: Red Cells, 0.8% Resolve Panel C Ordering Period 3 POP Begin: 11-01-2024 POP End: 10-31-2025 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals Blood Bank Reagents (Identification and Antibodies) 2002 50.00 PG ID-Micro Typing System, Anti IGG Gel Card Ordering Period 3 POP Begin: 11-01-2024 POP End: 10-31-2025 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals Blood Bank Reagents (Identification and Antibodies) 2003 12.00 BX ID- Micro Typing System Buffers, MTS Diluent 2, 100mL Ordering Period 4 POP Begin: 11-01-2024 POP End: 10-31-2025 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals Blood Bank Reagents (Identification and Antibodies) 3001 13.00 PG Reagent: Red Cells, 0.8% Resolve Panel C Ordering Period 4 POP Begin: 11-01-2025 POP End: 10-31-2026 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals Blood Bank Reagents (Identification and Antibodies) 3002 50.00 PG ID-Micro Typing System, Anti IGG Gel Card Ordering Period 4 POP Begin: 11-01-2025 POP End: 10-31-2026 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals Blood Bank Reagents (Identification and Antibodies) 3003 12.00 BX ID- Micro Typing System Buffers, MTS Diluent 2, 100mL Ordering Period 4 POP Begin: 11-01-2025 POP End: 10-31-2026 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals Blood Bank Reagents (Identification and Antibodies) 4001 13.00 PG Reagent: Red Cells, 0.8% Resolve Panel C Ordering Period 5 POP Begin: 11-01-2026 POP End: 10-31-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals Blood Bank Reagents (Identification and Antibodies) 4002 50.00 PG ID-Micro Typing System, Anti IGG Gel Card Ordering Period 5 POP Begin: 11-01-2026 POP End: 10-31-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals Blood Bank Reagents (Identification and Antibodies) 4003 12.00 BX ID- Micro Typing System Buffers, MTS Diluent 2, 100mL Ordering Period 5 POP Begin: 11-01-2026 POP End: 10-31-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals Blood Bank Reagents (Identification and Antibodies) The services being requested are for the reference laboratory testing of patient specimen. Services are to be performed at the VA North Texas Healthcare System, Laboratory, 4500 S. Lancaster Rd., Dallas, TX 75216. The provision at 52.212-1, Instructions to Offerors-Commercial, applies to this acquisition. The provision at 52.212-2, Evaluation-Commercial Items, applies to this acquisition. The evaluation criteria are technical acceptability and price. Under technical includes the ability to provide all of the requested items in accordance with the Statement of Work, provide a letter of authorization (if not the manufacturer) and a description of equal items, and have, at minimum, a Satisfactory past performance rating. Offerors are to provide a completed copy of the provision at 52.212-3, Offeror Representations and Certifications-Commercial Items, with its offer. The clause at 52.212-4, Contract Terms and Conditions-Commercial Items, applies to this acquisition. There are no addenda to this clause. The clause at 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders-Commercial Items, applies to this acquisition. The following clauses cited in this clause are applicable: FAR 52.203-19 Prohibition on Requiring Certain Internal Confidentiality Agreements or Statements (JAN 2017) FAR 52.204 10, Reporting Executive Compensation and First-Tier Subcontract Awards (JUN 2020) FAR 52.204 23, Prohibition on Contracting for Hardware, Software, and Services Developed or Provided by Kaspersky Lab and Other Covered Entities (Jul 2018) FAR 52.204 25, Prohibition on Contracting for Certain Telecommunications and Video Surveillance Services or Equipment. (AUG 2019) FAR 52.209 6, Protecting the Government s Interest When Subcontracting with Contractors Debarred, Suspended, or Proposed for Debarment. (NOV 2021) FAR 52.209-10, Prohibition on Contracting with Inverted Domestic Corporations (NOV 2015) FAR 52.219 4, Notice of Price Evaluation Preference for HUBZone Small Business Concerns (SEP 2021) FAR 52.233-3, Protest After Award (Aug 1996) FAR 52.233-4, Applicable Law for Breach of Contract Claim (Oct 2004) FAR 52.219-28, Post Award Small Business Program Rerepresentation (MAR 2020) FAR 52.222 19, Child Labor Cooperation with Authorities and Remedies (JUL 2020) (DEVIATION) FAR 52.222-21, Prohibition of Segregated Facilities (APR 2015) FAR 52.222 26, Equal Opportunity (SEP 2016) FAR 52.222-36, Equal Opportunity for Workers with Disabilities (JUN 2020) FAR 52.222-50, Combating Trafficking in Persons (JAN 2019) FAR 52.223 18, Encouraging Contractor Policies to Ban Text Messaging While Driving (JUN 2020) FAR 52.225 5, Trade Agreements (JUL 2020) (DEVIATION) FAR 52.225-13, Restrictions on Certain Foreign Purchases (FEB 2021) FAR 52.229 12, Tax on Certain Foreign Procurements (FEB 2021) FAR 52.232-33, Payment by Electronic Funds Transfer System for Award Management (Oct 2018) Additional Terms and Conditions: FAR 52.204-13, System for Award Management Maintenance (Oct 2018) FAR 52.204-18, Commercial and Government Entity Code Maintenance (JUL 2016) FAR 52.216-18, Ordering (AUG 2020) FAR 52.216-19, Order Limitations (OCT 1995) FAR 52.216-22, Indefinite Quantity (OCT 1995) FAR 52.217-8, Option to Extend Services (NOV 1999) FAR 52.232-18, Availability of Funds (APR 1984) FAR 52.232-40, Providing Accelerated Payments to Small Business Subcontractors (DEC 2013) FAR 52.317-3, Continuity of Services (JAN 1991) VAAR 852.212-70, Provisions and Clauses Applicable to VA Acquisition of Commercial Items (APR 2020) VAAR 852.203 70, Commercial Advertising VAAR 852.232 72, Electronic Submission of Payment Requests VAAR 852.246-71, Rejected Goods VAAR 852.270 1, Representatives of Contracting Officers VAAR 852.273 70, Late Offers (Provision) VAAR 852.212-71, Gray Market Items (APR 2020) VAAR 852.219-75, Subcontracting Commitments Monitoring and Compliance (JUL 2018) VAAR 852.242-71, Administrative Contracting Officer (OCT 2020) VAAR 852.247-73, Packing for Domestic Shipment (OCT 2018) Additional Provisions: FAR 52.204-7, System for Award Management (OCT 2018) FAR 52.204-16, Commercial and Government Entity Code Reporting (AUG 2020) FAR 52.204-24 Representation Regarding Telecommunications and Video Surveillance Services or Equipment (AUG 2019) FAR 52.209-7, Information Regarding Responsibility matters (OCT 2018) FAR 52.211-6, Brand Name or Equal (AUG 1999) FAR 52.214-21, Descriptive Literature (APR 2002) FAR 52.229-11, Tax on Certain Foreign Procurements Notice and Representation (JUN 2020) See attached RFQ document for more information. Late quotes or documentation may be accepted if advantageous to the Government. All comments or inquiries are to be submitted in writing via email to the Point of Contact, referenced above, prior to the closing of the question and answer period, July 20, 2022, at 1:00 p.m. ET. Vendors interested in providing the required supplies will need to submit all required documentation, detailed in the attached RFQ document, to Delphia Schoenfeld at [email protected], no later than July 29, 2022, 3 PM ET (2 PM CT).